Azelnidipine is a long-acting dihydropyridine calcium channel blocker offering smooth, sustained blood-pressure control with once-daily dosing, used mainly in Asian hypertension markets. Simson Pharma's Azelnidipine reference standard and impurities support generic development for this cardiovascular therapy.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Azelnidipine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.